ALL-IN-ONE Relief
usim.bestage.usimdesignsystem.com
Results in all key clinical manifestations of PsA and the hallmarks of disease that matter to patients with nr-axSpA
Job code (date)
Individual results may vary.
In Future 6
Fast relief as early as week 2 lorem ipsum dolor sit
Ask your rheumatologist if COSENTYX® may be right for you.
FUTURE 5 uncontrolled exploratory analysis: Nonresponder imputation in a subgroup of biologic-naive patients from Week 1 to Week 24.
Job code (date)
“These are precious times, and to see you help me be part of them.”
Darren, actual COSENTYX patient
ALL-IN-ONE Relief
Results in all key clinical manifest of PsA and the hallmarks of disease that matter to patients with nr-axSpA
Job code (date)
ALL-IN-ONE Relief
Results in all key clinical manifest of PsA and the hallmarks of disease that matter to patients with nr-axSpA
Job code (date)
Start Here to see what you can do with COSENTYX
Results in all key clinical manifest of PsA and the hallmarks of disease that matter to patients with signs nr-axSpA
Start Here to see what you
can do with COSENTYX
Results in all key clinical manifest of PsA and the
hallmarks of disease that matter to patients with signs
nr-axSpA
Fast relief as early as week 2 lorem ipsum dolor sit
ACR20 responses at Week 2 in a mixed population (exploratory analysis)
FUTURE 5 uncontrolled exploratory analysis: Nonresponder imputation in a subgroup of biologic-naive patients from Week 1 to Week 24. No clinical or statistical conclusions can be drawn.4,5
Individual results may vary.
In Future 5
Ask your rheumatologist if COSENTYX® may be right for you.
FUTURE 5 uncontrolled exploratory analysis: Nonresponder imputation in a subgroup of biologic-naive patients from Week 1 to Week 24.
Individual results may vary.
In Future 5
Ask your rheumatologist if COSENTYX® may be right for you.
FUTURE 5 uncontrolled exploratory analysis: Nonresponder imputation in a subgroup of biologic-naive patients from Week 1 to Week 24.
Fast relief as early as week 2 lorem ipsum dolor sit
ACR20 responses at Week 2 in a mixed population (exploratory analysis)
FUTURE 5 uncontrolled exploratory analysis: Nonresponder imputation in a subgroup of biologic-naive patients from Week 1 to Week 24. No clinical or statistical conclusions can be drawn.4,5
Individual results may vary.
In Future 5
Ask your rheumatologist if COSENTYX® may be right for you.
FUTURE 5 uncontrolled exploratory analysis: Nonresponder imputation in a subgroup of biologic-naive patients from Week 1 to Week 24.
Individual results may vary.
In Future 5
Ask your rheumatologist if COSENTYX® may be right for you.
FUTURE 5 uncontrolled exploratory analysis: Nonresponder imputation in a subgroup of biologic-naive patients from Week 1 to Week 24.
Individual results may vary.
In Future 5
Ask your rheumatologist if COSENTYX® may be right for you.
FUTURE 5 uncontrolled exploratory analysis: Nonresponder imputation in a subgroup of biologic-naive patients from Week 1 to Week 24.
Individual results may vary.
In Future 5
Ask your rheumatologist if COSENTYX® may be right for you.
FUTURE 5 uncontrolled exploratory analysis: Nonresponder imputation in a subgroup of biologic-naive patients from Week 1 to Week 24.